Liu F, Rothblum-Oviatt C, Ryan C E, Piwnica-Worms H
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110-1093, USA.
Mol Cell Biol. 1999 Jul;19(7):5113-23. doi: 10.1128/MCB.19.7.5113.
The Myt1 protein kinase functions to negatively regulate Cdc2-cyclin B complexes by phosphorylating Cdc2 on threonine 14 and tyrosine 15. Throughout interphase, human Myt1 localizes to the endoplasmic reticulum and Golgi complex, whereas Cdc2-cyclin B1 complexes shuttle between the nucleus and the cytoplasm. Here we report that overproduction of either kinase-active or kinase-inactive forms of Myt1 blocked the nuclear-cytoplasmic shuttling of cyclin B1 and caused cells to delay in the G2 phase of the cell cycle. The COOH-terminal 63 amino acids of Myt1 were identified as a Cdc2-cyclin B1 interaction domain. Myt1 mutants lacking this domain no longer bound cyclin B1 and did not efficiently phosphorylate Cdc2-cyclin B1 complexes in vitro. In addition, cells overproducing mutant forms of Myt1 lacking the interaction domain exhibited normal trafficking of cyclin B1 and unperturbed cell cycle progression. These results suggest that the docking of Cdc2-cyclin B1 complexes to the COOH terminus of Myt1 facilitates the phosphorylation of Cdc2 by Myt1 and that overproduction of Myt1 perturbs cell cycle progression by sequestering Cdc2-cyclin B1 complexes in the cytoplasm.
Myt1蛋白激酶通过磷酸化Cdc2的苏氨酸14和酪氨酸15来负向调节Cdc2-细胞周期蛋白B复合物。在整个间期,人类Myt1定位于内质网和高尔基体复合物,而Cdc2-细胞周期蛋白B1复合物在细胞核和细胞质之间穿梭。在此我们报道,Myt1的激酶活性形式或激酶无活性形式的过量表达均会阻断细胞周期蛋白B1的核质穿梭,并导致细胞在细胞周期的G2期延迟。Myt1的COOH末端63个氨基酸被鉴定为Cdc2-细胞周期蛋白B1相互作用结构域。缺乏该结构域的Myt1突变体不再结合细胞周期蛋白B1,并且在体外不能有效地磷酸化Cdc2-细胞周期蛋白B1复合物。此外,过量表达缺乏相互作用结构域的Myt1突变体的细胞表现出细胞周期蛋白B1的正常运输以及不受干扰的细胞周期进程。这些结果表明,Cdc2-细胞周期蛋白B1复合物与Myt1的COOH末端对接有助于Myt1对Cdc2的磷酸化作用,并且Myt1的过量表达通过将Cdc2-细胞周期蛋白B1复合物隔离在细胞质中而扰乱细胞周期进程。